Wells Fargo Maintains Conmed at Equal-Weight, Raises Target to $49
Wells Fargo maintained its Equal-Weight rating on Conmed and raised its price target to $49 from $46.
Story updates
02:16:01 PM UTC
SquawkNews
Conmed Price Target Raised to $49.00/Share From $46.00 by Wells Fargo